Clinical Impact of Blood Testosterone Concentration on Cardio-Ankle Vascular Index in Female Patients With Type 2 Diabetes Mellitus

Abstract

Background: Information regarding testosterone as a significant risk factor of cardiovascular disease (CVD) in female patients with type 2 diabetes mellitus (DM) is limited. However, some clinical studies reported the importance of cardio-ankle vascular index (CAVI) as a novel physiological marker of arterial function in type 2 DM. This cross-sectional study aimed to elucidate the clinical effects of blood testosterone concentration on CAVI in female patients with type 2 DM.

Methods: A total of 238 postmenopausal patients including 97 with a history of CVD with type 2 DM (age (mean standard deviation (SD)), 73 9 years) were enrolled. CAVI was measured according to the standard technique, and serum total testosterone concentration (T-T) was also measured as a testosterone level marker in vivo. The relationship between CAVI and T-T was evaluated.

Results: CAVI is significantly higher (CVD vs. non-CVD: 10.2 1.2 vs. 9.2 1.0, P < 0.001), and log-T-T significantly lower (CVD vs. non-CVD: 1.2 0.2 ng/dL vs. 1.5 0.2 ng/dL, P < 0.001) in patients with CVD than those without CVD. CAVI was significantly negatively correlated with log-T-T (r = -0.41; P < 0.001). Furthermore, multiple regression analysis indicated that CVD (beta = 0.23; P < 0.001) and log-T-T (beta = -0.18; P < 0.01) were selected as independent subordinate variables for CAVI.

Conclusions: This study showed that T-T was independently inversely associated with CAVI, indicating that low testosterone concentration is a considerable risk factor for the progression of arterial dysfunction in female patients with type 2 DM.




Cardiol Res. 2019;10(1):9-17
doi: https://doi.org/10.14740/cr827